Insight
New standard. New challenges.
The new standard introduces a core principle that requires companies to evaluate their transactions in a new way. This publication summarizes the most significant issues for the Life Sciences industry.
Related content
KPMG Healthcare & Life Sciences Institute
Register to receive timely insights
Register to receive timely insights
Subscribe now
About Healthcare & Life Sciences at KPMG
Our practice
Our capabilities
Meet our team